Roche Group (ROG.SW, RO.SW) said it achieved good results in the first half of the year due to the continued strong demand for its diagnostics base business and the new medicines to treat haemophilia, cancer and neurological disorders. Looking forward, the Group confirmed the outlook for the full year.
from RTT - Earnings https://ift.tt/qQe4CaI
via IFTTT
No comments:
Post a Comment